A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
[Full Story]
Surya N. Mohapatra net worth and biography

Surya Mohapatra Biography and Net Worth

Director of Leidos
Surya N. Mohapatra, Ph.D., has held senior leadership positions in the health care industry for more than 30 years, most recently as the Chairman, President and Chief Executive Officer of Quest Diagnostics Incorporated, the world’s leading provider of diagnostic testing, information and services where he had been a senior executive since 1999. Dr. Mohapatra’s experience as CEO brings deep and relevant expertise in innovation, resource allocation and risk management to our Board. Dr. Mohapatra is a past Board member of the ITT Corporation and is currently a member of the Board of Directors of Xylem Inc., a leading global water technology and transport company. He is also a Trustee of The Rockefeller University and an Executive in Residence at the Columbia Business School. Dr. Mohapatra holds a BS in Electrical Engineering from the Regional Engineering College, Rourkela, India; a Master of Science in Medical Electronics from the University of Salford, England; and a Doctorate in Medical Physics from the University of London and the Royal College of Surgeons of England.

What is Surya N. Mohapatra's net worth?

The estimated net worth of Surya N. Mohapatra is at least $1.73 million as of August 18th, 2022. Mr. Mohapatra owns 17,515 shares of Leidos stock worth more than $1,729,781 as of February 6th. This net worth estimate does not reflect any other investments that Mr. Mohapatra may own. Learn More about Surya N. Mohapatra's net worth.

How do I contact Surya N. Mohapatra?

The corporate mailing address for Mr. Mohapatra and other Leidos executives is 1750 PRESIDENTS STREET, RESTON VA, 20190. Leidos can also be reached via phone at (571) 526-6000 and via email at [email protected] Learn More on Surya N. Mohapatra's contact information.

Has Surya N. Mohapatra been buying or selling shares of Leidos?

Surya N. Mohapatra has not been actively trading shares of Leidos in the last ninety days. Most recently, Surya N. Mohapatra sold 3,155 shares of the business's stock in a transaction on Thursday, August 18th. The shares were sold at an average price of $101.52, for a transaction totalling $320,295.60. Following the completion of the sale, the director now directly owns 17,515 shares of the company's stock, valued at $1,778,122.80. Learn More on Surya N. Mohapatra's trading history.

Who are Leidos' active insiders?

Leidos' insider roster includes David Fubini (Director), Harry Jansen Kraemer, Jr. (Director), Miriam John (Director), Roger Krone (CEO), Gary May (Director), Surya Mohapatra (Director), James Moos (Insider), and Roy Stevens (Insider). Learn More on Leidos' active insiders.

Are insiders buying or selling shares of Leidos?

In the last twelve months, insiders at the aerospace company sold shares 14 times. They sold a total of 137,495 shares worth more than $14,578,467.06. The most recent insider tranaction occured on December, 13th when Director David G Fubini sold 6,189 shares worth more than $675,838.80. Insiders at Leidos own 1.7% of the company. Learn More about insider trades at Leidos.

Information on this page was last updated on 12/13/2022.

Surya N. Mohapatra Insider Trading History at Leidos

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/18/2022Sell3,155$101.52$320,295.6017,515View SEC Filing Icon  
11/11/2016Buy3,276$46.27$151,580.529,419View SEC Filing Icon  
9/13/2016Buy3,575$41.48$148,291.006,143View SEC Filing Icon  
See Full Table

Surya N. Mohapatra Buying and Selling Activity at Leidos

This chart shows Surya N Mohapatra's buying and selling at Leidos by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Leidos Company Overview

Leidos logo
Leidos Holdings, Inc. is a holding company, which engages in the provision of scientific, engineering and information technology services and solutions in the areas of defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment focuses on deploying agile, cost-effective solutions to meet the ever-changing missions of the company's customers in areas of intelligence surveillance and reconnaissance, enterprise IT and integrated systems and cybersecurity and global services. The Civil segment focuses on seamlessly integrating and protecting physical, digital and data domains. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on June 1, 1969, and is headquartered in Reston, VA.
Read More

Today's Range

Now: $98.34
Low: $97.98
High: $99.26

50 Day Range

MA: $102.99
Low: $94.57
High: $110.49

2 Week Range

Now: $98.34
Low: $81.07
High: $111.12

Volume

605,454 shs

Average Volume

841,936 shs

Market Capitalization

$13.44 billion

P/E Ratio

20.11

Dividend Yield

1.47%

Beta

0.77
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
[Full Story]